Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma

A. Younes, G. Salles, G. Martinelli, R.G. Bociek, D.C. Barrigon, E.G. Barca, M. Turgut, J. Gerecitano, O. Kong, C.B. Pisal, R. Tavorath, W.S. Kim

Research output: Contribution to journalArticle

Cite this

Younes, A., Salles, G., Martinelli, G., Bociek, R. G., Barrigon, D. C., Barca, E. G., Turgut, M., Gerecitano, J., Kong, O., Pisal, C. B., Tavorath, R., & Kim, W. S. (2017). Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma. Haematologica, 102(12), 2104-2112. https://doi.org/10.3324/haematol.2017.169656